Vice President & Head, Clinical Operations-Oncology
About me
Tracy Vanderslice currently serves as Vice President and Head of Clinical Operations at Gilead Sciences. In this role, she leads a large global team to support operational delivery across the oncology portfolio. Prior to joining Gilead, she led global teams at GSK in clinical operations and delivery as well as pharmacology sciences and operations. Tracy has extensive experience across multiple therapeutic areas, including oncology, respiratory, infectious diseases, immunology, neurosciences, cardiovascular, and metabolic diseases. Her expertise in clinical operations spans Phase 1 trials to post-marketing commitments and submissions. Tracy is dedicated to advancing patient-centered design, innovative trial methodologies, clinical trial diversity, health equity, and digital health—all with the goal of accelerating the delivery of medicines to patients in need.